Cure rate of low-risk superficial basal cell carcinoma treated with topical 5-fluorouracil
Background: Basal cell carcinoma (BCC) is the most common cancer in the world making this condition a public health issue. Superficial BCC (sBCC) is a subtype with indolent behavior. The gold standard treatment is the surgical resection, however, sBCC can be treated with more cost-effective noninv...
Saved in:
| Main Authors: | Camilo E Alarcón Pérez, Santiago A. Ariza-Gómez, Samuel D. Morales-Naranjo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Asociación Colombiana de Dermatología y Cirugía Dermatológica
2024-07-01
|
| Series: | Revista de la Asociación Colombiana de Dermatología y Cirugía Dermatológica |
| Subjects: | |
| Online Access: | https://revista.asocolderma.org.co/index.php/asocolderma/article/view/1834 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nevoid basal cell carcinoma syndrome (Gorlin syndrome): a case report
by: Noura Abdul Rahman, et al.
Published: (2025-01-01) -
Clinical and pathological characteristics of multiple superficial basal cell carcinoma: A report of 6 cases
by: HE Pingxiu, et al.
Published: (2025-02-01) -
Clinical case of basal cell carcinoma therapy using 5 % imiquimod cream
by: H. I. Makurina, et al.
Published: (2020-08-01) -
Superficial skin infections and the use of topical and systemic antibiotics in general practice
by: M.H. Motswaledi
Published: (2011-04-01) -
Successful desensitization with 5-fluorouracil in a patient who developed anaphylaxis after 5-fluorouracil infusion
by: Mehmet Erdem Çakmak, et al.
Published: (2024-08-01)